Frequently Asked Questions
Frequently asked questions
Meet the experts
Resources

If you have questions about genital herpes…

you may find some answers here. This information does not replace the advice of a healthcare professional. If you have any questions about genital herpes, always consult your doctor.

Your Questions Answered

Knowledge is power

Today’s people are more informed about their health than ever before and you should be no exception. Knowledge gives you the power to take an active role in your management of genital herpes.

Here, you will find answers to frequently asked questions, help lines to call, books to inform you and organizations to support you as you learn how to take charge of genital herpes in your life.






 
1. Sacks SL. The Truth About Herpes. 4th ed. West Vancouver, BC: Gordon Soules Book Publishers Ltd.;1997..

2. Patrick DM, Dawar M, Cook DA, et al. Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women. Sex Transm Dis. 2001;28(7):424-8.

3. Aoki FY. Canadian Guidelines on Sexually Transmitted Infections 2006 Edition: Genital Herpes Simplex Virus (HSV) Infections. Public Health Agency of Canada http://phac-aspc.gc.ca/std-mts/sti_2006/pdf/sti2006_e.pdf. Accessed May 15, 2006.

4. Whitley RJ, Kimberlin DW, Roizman B. Herpes simplex viruses. Clin Infect Dis. 1998;26(3):541-53.

5. Mertz GJ, Benedetti J, Ashley R, et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992;116(3):197-202.

6. Boon RJ, Bacon TH, Robey HL, et al. Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialie [sic]: A UK-based survey. J Antimicrob Chemother 2000;46(2):324-325.

7. Valtrex® (valacyclovir hydrochloride) Product Monograph. GlaxoSmithKline Inc., May 2006.

8. Wald A, Langenbrerg AGM, Link K et al. Effect of condoms on reducting the transmission of herpes simplex virus type 2 from men to women. JAMA 2001:285(24):3100-3106.

9. Ribes JA, Steele AD, Seabolt JP et al. Six-Year Study of the Incidence of Herpes in Genital and Nongenital Cultures in a Central Kentucky Medical Center Patient Population. J Clin Microbiol 2001;39(9):3321-3325.

10. Wald A, Zeh J, Selke S, et al. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995;333(12):770-5.

11 Wald A, Zeh J, Selke S, et al. Genital shedding of herpes simplex virus among men. J Infect Dis 2002;186:S34-9.

12. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-analysis. J Infect Dis 2002;185(1):45-52.

13. McFarland W, Gwanzura L, Bassett MT, et al. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. J Infect Dis 1999;180(5):1459-1465.

14. Benedetti JK, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 1999;131(1):14-20.

15. Health Canada. What You Need to Know About Sexually Transmitted Infections. Ottawa, ON: Health Canada. 2002. Available at www.hc-sc.gc.ca/pphb-dgspsp/publicat/std-mts/index.html and www.hc-sc.gc.ca/iyh-vsv/diseases-maladies/gonorrh_e.html.

16. Famvir® (famciclovir) Product Monograph. Novartis Pharmaceuticals Canada Inc.; January 2004.

17. Zovirax® Oral (acyclovir) Product Monograph. GlaxoSmithKline Inc.; March 2007.

Print l Email